Inovio Pharmaceuticals (INO)

Inovio Pharmaceuticals (INO) Financial Statements


Inovio Pharmaceuticals Financial Overview

Inovio Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-1.186; its P/E ratio is -0.80; Inovio Pharmaceuticals is scheduled to report earnings on May 10, 2023, and the estimated EPS forecast is $-0.14. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue$ 124.67K$ 9.15M$ 784.39K$ 199.07K$ 839.12K
Gross Profit-----
EBIT$ -54.15M$ -37.47M$ -108.18M$ -76.60M$ -106.47M
EBITDA$ -52.80M$ -36.11M$ -106.77M$ -75.22M$ -104.23M
Net Income Common Stockholders$ -54.46M$ -37.78M$ -108.50M$ -79.07M$ -106.95M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 253.00M$ 281.88M$ 348.13M$ 360.39M$ 401.31M
Total Assets$ 348.53M$ 391.97M$ 459.40M$ 445.51M$ 495.94M
Total Debt$ 32.07M$ 32.43M$ 33.31M$ 33.65M$ 33.02M
Net Debt$ -220.92M$ -249.45M$ -314.81M$ -326.75M$ -368.29M
Total Liabilities$ 126.17M$ 125.27M$ 161.73M$ 90.43M$ 96.27M
Stockholders Equity$ 222.36M$ 266.70M$ 297.67M$ 355.09M$ 399.67M
Cash Flow-
Free Cash Flow$ -36.51M$ -67.55M$ -51.25M$ -61.88M$ -38.53M
Operating Cash Flow$ -36.34M$ -67.47M$ -50.53M$ -61.88M$ -37.89M
Investing Cash Flow$ 54.00M$ 44.56M$ -10.30M$ 21.33M$ -6.49M
Financing Cash Flow$ 6.67M$ 3.81M$ 42.94M$ 28.42M$ 47.59M
Currency in USD

Inovio Pharmaceuticals Earnings and Revenue History

Inovio Pharmaceuticals Debt to Assets

Inovio Pharmaceuticals Cash Flow

Inovio Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis